The pharmaceutical group added that sales of its Covid-19 vaccine Vaxzevria slumped 49 per cent in the second quarter.
AstraZeneca's statement says that the phase-three trial was carried out mostly on participants 'at high risk of progression to severe Covid-19'.
On the collaboration with SASTRA, Siva Padmanabhan, the Managing Director of AZIPL, said,
All the 5000 trees being planted under this programme in Bengaluru will have smart geo-tags enabling individualistic tracking of each remotely
Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.